Global AI-driven Drug Discovery Market Growth (Status and Outlook) 2026-2032
The global AI-driven Drug Discovery market size is predicted to grow from US$ 884 million in 2025 to US$ 1798 million in 2032; it is expected to grow at a CAGR of 10.9% from 2026 to 2032.
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “AI-driven Drug Discovery Industry Forecast” looks at past sales and reviews total world AI-driven Drug Discovery sales in 2025, providing a comprehensive analysis by region and market sector of projected AI-driven Drug Discovery sales for 2026 through 2032. With AI-driven Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-driven Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global AI-driven Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-driven Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-driven Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-driven Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-driven Drug Discovery.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-driven Drug Discovery market by product type, application, key players and key regions and countries.
Segmentation by Type:
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “AI-driven Drug Discovery Industry Forecast” looks at past sales and reviews total world AI-driven Drug Discovery sales in 2025, providing a comprehensive analysis by region and market sector of projected AI-driven Drug Discovery sales for 2026 through 2032. With AI-driven Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-driven Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global AI-driven Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-driven Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-driven Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-driven Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-driven Drug Discovery.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-driven Drug Discovery market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Small Molecule Drug
- Biological Modeling
- Structural Biology
- Others
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Entos
- Selvita
- Benevolent
- Exscientia
- Euretos
- Illumina with AstraZeneca
- Novo Nordisk with Microsoft
- Iktos
- Aqemia
- Zephyr AI
- Cyclicarx
- Eli Lilly
- Terray Therapeutics
- Ardigen
- ReviveMed
- Insilico Medicine
- XtalPi
- MindRank
- DP Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI-driven Drug Discovery Market Size (2021-2032)
2.1.2 AI-driven Drug Discovery Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI-driven Drug Discovery by Country/Region (2021, 2025 & 2032)
2.2 AI-driven Drug Discovery Segment by Type
2.2.1 Small Molecule Drug
2.2.2 Biological Modeling
2.2.3 Structural Biology
2.2.4 Others
2.2.5 AI-driven Drug Discovery Market Size by Type
2.2.5.1 AI-driven Drug Discovery Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
2.3 AI-driven Drug Discovery Segment by Application
2.3.1 Pharmaceutical and Biotechnology Companies
2.3.2 Research Laboratories
2.3.3 AI-driven Drug Discovery Market Size by Application
2.3.3.1 AI-driven Drug Discovery Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
3 AI-DRIVEN DRUG DISCOVERY MARKET SIZE BY PLAYER
3.1 AI-driven Drug Discovery Market Size Market Share by Player
3.1.1 Global AI-driven Drug Discovery Revenue by Player (2021-2026)
3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Player (2021-2026)
3.2 Global AI-driven Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-DRIVEN DRUG DISCOVERY BY REGION
4.1 AI-driven Drug Discovery Market Size by Region (2021-2026)
4.2 Global AI-driven Drug Discovery Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI-driven Drug Discovery Market Size Growth (2021-2026)
4.4 APAC AI-driven Drug Discovery Market Size Growth (2021-2026)
4.5 Europe AI-driven Drug Discovery Market Size Growth (2021-2026)
4.6 Middle East & Africa AI-driven Drug Discovery Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI-driven Drug Discovery Market Size by Country (2021-2026)
5.2 Americas AI-driven Drug Discovery Market Size by Type (2021-2026)
5.3 Americas AI-driven Drug Discovery Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-driven Drug Discovery Market Size by Region (2021-2026)
6.2 APAC AI-driven Drug Discovery Market Size by Type (2021-2026)
6.3 APAC AI-driven Drug Discovery Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI-driven Drug Discovery Market Size by Country (2021-2026)
7.2 Europe AI-driven Drug Discovery Market Size by Type (2021-2026)
7.3 Europe AI-driven Drug Discovery Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI-driven Drug Discovery by Region (2021-2026)
8.2 Middle East & Africa AI-driven Drug Discovery Market Size by Type (2021-2026)
8.3 Middle East & Africa AI-driven Drug Discovery Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI-DRIVEN DRUG DISCOVERY MARKET FORECAST
10.1 Global AI-driven Drug Discovery Forecast by Region (2027-2032)
10.1.1 Global AI-driven Drug Discovery Forecast by Region (2027-2032)
10.1.2 Americas AI-driven Drug Discovery Forecast
10.1.3 APAC AI-driven Drug Discovery Forecast
10.1.4 Europe AI-driven Drug Discovery Forecast
10.1.5 Middle East & Africa AI-driven Drug Discovery Forecast
10.2 Americas AI-driven Drug Discovery Forecast by Country (2027-2032)
10.2.1 United States Market AI-driven Drug Discovery Forecast
10.2.2 Canada Market AI-driven Drug Discovery Forecast
10.2.3 Mexico Market AI-driven Drug Discovery Forecast
10.2.4 Brazil Market AI-driven Drug Discovery Forecast
10.3 APAC AI-driven Drug Discovery Forecast by Region (2027-2032)
10.3.1 China AI-driven Drug Discovery Market Forecast
10.3.2 Japan Market AI-driven Drug Discovery Forecast
10.3.3 Korea Market AI-driven Drug Discovery Forecast
10.3.4 Southeast Asia Market AI-driven Drug Discovery Forecast
10.3.5 India Market AI-driven Drug Discovery Forecast
10.3.6 Australia Market AI-driven Drug Discovery Forecast
10.4 Europe AI-driven Drug Discovery Forecast by Country (2027-2032)
10.4.1 Germany Market AI-driven Drug Discovery Forecast
10.4.2 France Market AI-driven Drug Discovery Forecast
10.4.3 UK Market AI-driven Drug Discovery Forecast
10.4.4 Italy Market AI-driven Drug Discovery Forecast
10.4.5 Russia Market AI-driven Drug Discovery Forecast
10.5 Middle East & Africa AI-driven Drug Discovery Forecast by Region (2027-2032)
10.5.1 Egypt Market AI-driven Drug Discovery Forecast
10.5.2 South Africa Market AI-driven Drug Discovery Forecast
10.5.3 Israel Market AI-driven Drug Discovery Forecast
10.5.4 Turkey Market AI-driven Drug Discovery Forecast
10.6 Global AI-driven Drug Discovery Forecast by Type (2027-2032)
10.7 Global AI-driven Drug Discovery Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI-driven Drug Discovery Forecast
11 KEY PLAYERS ANALYSIS
11.1 Entos
11.1.1 Entos Company Information
11.1.2 Entos AI-driven Drug Discovery Product Offered
11.1.3 Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Entos Main Business Overview
11.1.5 Entos Latest Developments
11.2 Selvita
11.2.1 Selvita Company Information
11.2.2 Selvita AI-driven Drug Discovery Product Offered
11.2.3 Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Selvita Main Business Overview
11.2.5 Selvita Latest Developments
11.3 Benevolent
11.3.1 Benevolent Company Information
11.3.2 Benevolent AI-driven Drug Discovery Product Offered
11.3.3 Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Benevolent Main Business Overview
11.3.5 Benevolent Latest Developments
11.4 Exscientia
11.4.1 Exscientia Company Information
11.4.2 Exscientia AI-driven Drug Discovery Product Offered
11.4.3 Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Exscientia Main Business Overview
11.4.5 Exscientia Latest Developments
11.5 Euretos
11.5.1 Euretos Company Information
11.5.2 Euretos AI-driven Drug Discovery Product Offered
11.5.3 Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Euretos Main Business Overview
11.5.5 Euretos Latest Developments
11.6 Illumina with AstraZeneca
11.6.1 Illumina with AstraZeneca Company Information
11.6.2 Illumina with AstraZeneca AI-driven Drug Discovery Product Offered
11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Illumina with AstraZeneca Main Business Overview
11.6.5 Illumina with AstraZeneca Latest Developments
11.7 Novo Nordisk with Microsoft
11.7.1 Novo Nordisk with Microsoft Company Information
11.7.2 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Offered
11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novo Nordisk with Microsoft Main Business Overview
11.7.5 Novo Nordisk with Microsoft Latest Developments
11.8 Iktos
11.8.1 Iktos Company Information
11.8.2 Iktos AI-driven Drug Discovery Product Offered
11.8.3 Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Iktos Main Business Overview
11.8.5 Iktos Latest Developments
11.9 Aqemia
11.9.1 Aqemia Company Information
11.9.2 Aqemia AI-driven Drug Discovery Product Offered
11.9.3 Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aqemia Main Business Overview
11.9.5 Aqemia Latest Developments
11.10 Zephyr AI
11.10.1 Zephyr AI Company Information
11.10.2 Zephyr AI AI-driven Drug Discovery Product Offered
11.10.3 Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Zephyr AI Main Business Overview
11.10.5 Zephyr AI Latest Developments
11.11 Cyclicarx
11.11.1 Cyclicarx Company Information
11.11.2 Cyclicarx AI-driven Drug Discovery Product Offered
11.11.3 Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cyclicarx Main Business Overview
11.11.5 Cyclicarx Latest Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Information
11.12.2 Eli Lilly AI-driven Drug Discovery Product Offered
11.12.3 Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Eli Lilly Main Business Overview
11.12.5 Eli Lilly Latest Developments
11.13 Terray Therapeutics
11.13.1 Terray Therapeutics Company Information
11.13.2 Terray Therapeutics AI-driven Drug Discovery Product Offered
11.13.3 Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Terray Therapeutics Main Business Overview
11.13.5 Terray Therapeutics Latest Developments
11.14 Ardigen
11.14.1 Ardigen Company Information
11.14.2 Ardigen AI-driven Drug Discovery Product Offered
11.14.3 Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Ardigen Main Business Overview
11.14.5 Ardigen Latest Developments
11.15 ReviveMed
11.15.1 ReviveMed Company Information
11.15.2 ReviveMed AI-driven Drug Discovery Product Offered
11.15.3 ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 ReviveMed Main Business Overview
11.15.5 ReviveMed Latest Developments
11.16 Insilico Medicine
11.16.1 Insilico Medicine Company Information
11.16.2 Insilico Medicine AI-driven Drug Discovery Product Offered
11.16.3 Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Insilico Medicine Main Business Overview
11.16.5 Insilico Medicine Latest Developments
11.17 XtalPi
11.17.1 XtalPi Company Information
11.17.2 XtalPi AI-driven Drug Discovery Product Offered
11.17.3 XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 XtalPi Main Business Overview
11.17.5 XtalPi Latest Developments
11.18 MindRank
11.18.1 MindRank Company Information
11.18.2 MindRank AI-driven Drug Discovery Product Offered
11.18.3 MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 MindRank Main Business Overview
11.18.5 MindRank Latest Developments
11.19 DP Technology
11.19.1 DP Technology Company Information
11.19.2 DP Technology AI-driven Drug Discovery Product Offered
11.19.3 DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 DP Technology Main Business Overview
11.19.5 DP Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI-driven Drug Discovery Market Size (2021-2032)
2.1.2 AI-driven Drug Discovery Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI-driven Drug Discovery by Country/Region (2021, 2025 & 2032)
2.2 AI-driven Drug Discovery Segment by Type
2.2.1 Small Molecule Drug
2.2.2 Biological Modeling
2.2.3 Structural Biology
2.2.4 Others
2.2.5 AI-driven Drug Discovery Market Size by Type
2.2.5.1 AI-driven Drug Discovery Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
2.3 AI-driven Drug Discovery Segment by Application
2.3.1 Pharmaceutical and Biotechnology Companies
2.3.2 Research Laboratories
2.3.3 AI-driven Drug Discovery Market Size by Application
2.3.3.1 AI-driven Drug Discovery Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
3 AI-DRIVEN DRUG DISCOVERY MARKET SIZE BY PLAYER
3.1 AI-driven Drug Discovery Market Size Market Share by Player
3.1.1 Global AI-driven Drug Discovery Revenue by Player (2021-2026)
3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Player (2021-2026)
3.2 Global AI-driven Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-DRIVEN DRUG DISCOVERY BY REGION
4.1 AI-driven Drug Discovery Market Size by Region (2021-2026)
4.2 Global AI-driven Drug Discovery Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI-driven Drug Discovery Market Size Growth (2021-2026)
4.4 APAC AI-driven Drug Discovery Market Size Growth (2021-2026)
4.5 Europe AI-driven Drug Discovery Market Size Growth (2021-2026)
4.6 Middle East & Africa AI-driven Drug Discovery Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI-driven Drug Discovery Market Size by Country (2021-2026)
5.2 Americas AI-driven Drug Discovery Market Size by Type (2021-2026)
5.3 Americas AI-driven Drug Discovery Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-driven Drug Discovery Market Size by Region (2021-2026)
6.2 APAC AI-driven Drug Discovery Market Size by Type (2021-2026)
6.3 APAC AI-driven Drug Discovery Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI-driven Drug Discovery Market Size by Country (2021-2026)
7.2 Europe AI-driven Drug Discovery Market Size by Type (2021-2026)
7.3 Europe AI-driven Drug Discovery Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI-driven Drug Discovery by Region (2021-2026)
8.2 Middle East & Africa AI-driven Drug Discovery Market Size by Type (2021-2026)
8.3 Middle East & Africa AI-driven Drug Discovery Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI-DRIVEN DRUG DISCOVERY MARKET FORECAST
10.1 Global AI-driven Drug Discovery Forecast by Region (2027-2032)
10.1.1 Global AI-driven Drug Discovery Forecast by Region (2027-2032)
10.1.2 Americas AI-driven Drug Discovery Forecast
10.1.3 APAC AI-driven Drug Discovery Forecast
10.1.4 Europe AI-driven Drug Discovery Forecast
10.1.5 Middle East & Africa AI-driven Drug Discovery Forecast
10.2 Americas AI-driven Drug Discovery Forecast by Country (2027-2032)
10.2.1 United States Market AI-driven Drug Discovery Forecast
10.2.2 Canada Market AI-driven Drug Discovery Forecast
10.2.3 Mexico Market AI-driven Drug Discovery Forecast
10.2.4 Brazil Market AI-driven Drug Discovery Forecast
10.3 APAC AI-driven Drug Discovery Forecast by Region (2027-2032)
10.3.1 China AI-driven Drug Discovery Market Forecast
10.3.2 Japan Market AI-driven Drug Discovery Forecast
10.3.3 Korea Market AI-driven Drug Discovery Forecast
10.3.4 Southeast Asia Market AI-driven Drug Discovery Forecast
10.3.5 India Market AI-driven Drug Discovery Forecast
10.3.6 Australia Market AI-driven Drug Discovery Forecast
10.4 Europe AI-driven Drug Discovery Forecast by Country (2027-2032)
10.4.1 Germany Market AI-driven Drug Discovery Forecast
10.4.2 France Market AI-driven Drug Discovery Forecast
10.4.3 UK Market AI-driven Drug Discovery Forecast
10.4.4 Italy Market AI-driven Drug Discovery Forecast
10.4.5 Russia Market AI-driven Drug Discovery Forecast
10.5 Middle East & Africa AI-driven Drug Discovery Forecast by Region (2027-2032)
10.5.1 Egypt Market AI-driven Drug Discovery Forecast
10.5.2 South Africa Market AI-driven Drug Discovery Forecast
10.5.3 Israel Market AI-driven Drug Discovery Forecast
10.5.4 Turkey Market AI-driven Drug Discovery Forecast
10.6 Global AI-driven Drug Discovery Forecast by Type (2027-2032)
10.7 Global AI-driven Drug Discovery Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI-driven Drug Discovery Forecast
11 KEY PLAYERS ANALYSIS
11.1 Entos
11.1.1 Entos Company Information
11.1.2 Entos AI-driven Drug Discovery Product Offered
11.1.3 Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Entos Main Business Overview
11.1.5 Entos Latest Developments
11.2 Selvita
11.2.1 Selvita Company Information
11.2.2 Selvita AI-driven Drug Discovery Product Offered
11.2.3 Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Selvita Main Business Overview
11.2.5 Selvita Latest Developments
11.3 Benevolent
11.3.1 Benevolent Company Information
11.3.2 Benevolent AI-driven Drug Discovery Product Offered
11.3.3 Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Benevolent Main Business Overview
11.3.5 Benevolent Latest Developments
11.4 Exscientia
11.4.1 Exscientia Company Information
11.4.2 Exscientia AI-driven Drug Discovery Product Offered
11.4.3 Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Exscientia Main Business Overview
11.4.5 Exscientia Latest Developments
11.5 Euretos
11.5.1 Euretos Company Information
11.5.2 Euretos AI-driven Drug Discovery Product Offered
11.5.3 Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Euretos Main Business Overview
11.5.5 Euretos Latest Developments
11.6 Illumina with AstraZeneca
11.6.1 Illumina with AstraZeneca Company Information
11.6.2 Illumina with AstraZeneca AI-driven Drug Discovery Product Offered
11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Illumina with AstraZeneca Main Business Overview
11.6.5 Illumina with AstraZeneca Latest Developments
11.7 Novo Nordisk with Microsoft
11.7.1 Novo Nordisk with Microsoft Company Information
11.7.2 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Offered
11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novo Nordisk with Microsoft Main Business Overview
11.7.5 Novo Nordisk with Microsoft Latest Developments
11.8 Iktos
11.8.1 Iktos Company Information
11.8.2 Iktos AI-driven Drug Discovery Product Offered
11.8.3 Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Iktos Main Business Overview
11.8.5 Iktos Latest Developments
11.9 Aqemia
11.9.1 Aqemia Company Information
11.9.2 Aqemia AI-driven Drug Discovery Product Offered
11.9.3 Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aqemia Main Business Overview
11.9.5 Aqemia Latest Developments
11.10 Zephyr AI
11.10.1 Zephyr AI Company Information
11.10.2 Zephyr AI AI-driven Drug Discovery Product Offered
11.10.3 Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Zephyr AI Main Business Overview
11.10.5 Zephyr AI Latest Developments
11.11 Cyclicarx
11.11.1 Cyclicarx Company Information
11.11.2 Cyclicarx AI-driven Drug Discovery Product Offered
11.11.3 Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cyclicarx Main Business Overview
11.11.5 Cyclicarx Latest Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Information
11.12.2 Eli Lilly AI-driven Drug Discovery Product Offered
11.12.3 Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Eli Lilly Main Business Overview
11.12.5 Eli Lilly Latest Developments
11.13 Terray Therapeutics
11.13.1 Terray Therapeutics Company Information
11.13.2 Terray Therapeutics AI-driven Drug Discovery Product Offered
11.13.3 Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Terray Therapeutics Main Business Overview
11.13.5 Terray Therapeutics Latest Developments
11.14 Ardigen
11.14.1 Ardigen Company Information
11.14.2 Ardigen AI-driven Drug Discovery Product Offered
11.14.3 Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Ardigen Main Business Overview
11.14.5 Ardigen Latest Developments
11.15 ReviveMed
11.15.1 ReviveMed Company Information
11.15.2 ReviveMed AI-driven Drug Discovery Product Offered
11.15.3 ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 ReviveMed Main Business Overview
11.15.5 ReviveMed Latest Developments
11.16 Insilico Medicine
11.16.1 Insilico Medicine Company Information
11.16.2 Insilico Medicine AI-driven Drug Discovery Product Offered
11.16.3 Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Insilico Medicine Main Business Overview
11.16.5 Insilico Medicine Latest Developments
11.17 XtalPi
11.17.1 XtalPi Company Information
11.17.2 XtalPi AI-driven Drug Discovery Product Offered
11.17.3 XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 XtalPi Main Business Overview
11.17.5 XtalPi Latest Developments
11.18 MindRank
11.18.1 MindRank Company Information
11.18.2 MindRank AI-driven Drug Discovery Product Offered
11.18.3 MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 MindRank Main Business Overview
11.18.5 MindRank Latest Developments
11.19 DP Technology
11.19.1 DP Technology Company Information
11.19.2 DP Technology AI-driven Drug Discovery Product Offered
11.19.3 DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 DP Technology Main Business Overview
11.19.5 DP Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AI-driven Drug Discovery Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI-driven Drug Discovery Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Small Molecule Drug
Table 4. Major Players of Biological Modeling
Table 5. Major Players of Structural Biology
Table 6. Major Players of Others
Table 7. AI-driven Drug Discovery Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 9. Global AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Table 10. AI-driven Drug Discovery Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 12. Global AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Table 13. Global AI-driven Drug Discovery Revenue by Player (2021-2026) & ($ millions)
Table 14. Global AI-driven Drug Discovery Revenue Market Share by Player (2021-2026)
Table 15. AI-driven Drug Discovery Key Players Head office and Products Offered
Table 16. AI-driven Drug Discovery Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global AI-driven Drug Discovery Market Size by Region (2021-2026) & ($ millions)
Table 20. Global AI-driven Drug Discovery Market Size Market Share by Region (2021-2026)
Table 21. Global AI-driven Drug Discovery Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global AI-driven Drug Discovery Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas AI-driven Drug Discovery Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas AI-driven Drug Discovery Market Size Market Share by Country (2021-2026)
Table 25. Americas AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Table 27. Americas AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Table 29. APAC AI-driven Drug Discovery Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC AI-driven Drug Discovery Market Size Market Share by Region (2021-2026)
Table 31. APAC AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe AI-driven Drug Discovery Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe AI-driven Drug Discovery Market Size Market Share by Country (2021-2026)
Table 35. Europe AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa AI-driven Drug Discovery Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of AI-driven Drug Discovery
Table 41. Key Market Challenges & Risks of AI-driven Drug Discovery
Table 42. Key Industry Trends of AI-driven Drug Discovery
Table 43. Global AI-driven Drug Discovery Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global AI-driven Drug Discovery Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global AI-driven Drug Discovery Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global AI-driven Drug Discovery Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Entos Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 48. Entos AI-driven Drug Discovery Product Offered
Table 49. Entos AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Entos Main Business
Table 51. Entos Latest Developments
Table 52. Selvita Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 53. Selvita AI-driven Drug Discovery Product Offered
Table 54. Selvita AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Selvita Main Business
Table 56. Selvita Latest Developments
Table 57. Benevolent Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 58. Benevolent AI-driven Drug Discovery Product Offered
Table 59. Benevolent AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Benevolent Main Business
Table 61. Benevolent Latest Developments
Table 62. Exscientia Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 63. Exscientia AI-driven Drug Discovery Product Offered
Table 64. Exscientia AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Exscientia Main Business
Table 66. Exscientia Latest Developments
Table 67. Euretos Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 68. Euretos AI-driven Drug Discovery Product Offered
Table 69. Euretos AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Euretos Main Business
Table 71. Euretos Latest Developments
Table 72. Illumina with AstraZeneca Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 73. Illumina with AstraZeneca AI-driven Drug Discovery Product Offered
Table 74. Illumina with AstraZeneca AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Illumina with AstraZeneca Main Business
Table 76. Illumina with AstraZeneca Latest Developments
Table 77. Novo Nordisk with Microsoft Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 78. Novo Nordisk with Microsoft AI-driven Drug Discovery Product Offered
Table 79. Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Novo Nordisk with Microsoft Main Business
Table 81. Novo Nordisk with Microsoft Latest Developments
Table 82. Iktos Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 83. Iktos AI-driven Drug Discovery Product Offered
Table 84. Iktos AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Iktos Main Business
Table 86. Iktos Latest Developments
Table 87. Aqemia Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 88. Aqemia AI-driven Drug Discovery Product Offered
Table 89. Aqemia AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Aqemia Main Business
Table 91. Aqemia Latest Developments
Table 92. Zephyr AI Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 93. Zephyr AI AI-driven Drug Discovery Product Offered
Table 94. Zephyr AI AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Zephyr AI Main Business
Table 96. Zephyr AI Latest Developments
Table 97. Cyclicarx Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 98. Cyclicarx AI-driven Drug Discovery Product Offered
Table 99. Cyclicarx AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Cyclicarx Main Business
Table 101. Cyclicarx Latest Developments
Table 102. Eli Lilly Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 103. Eli Lilly AI-driven Drug Discovery Product Offered
Table 104. Eli Lilly AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Eli Lilly Main Business
Table 106. Eli Lilly Latest Developments
Table 107. Terray Therapeutics Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 108. Terray Therapeutics AI-driven Drug Discovery Product Offered
Table 109. Terray Therapeutics AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Terray Therapeutics Main Business
Table 111. Terray Therapeutics Latest Developments
Table 112. Ardigen Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 113. Ardigen AI-driven Drug Discovery Product Offered
Table 114. Ardigen AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Ardigen Main Business
Table 116. Ardigen Latest Developments
Table 117. ReviveMed Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 118. ReviveMed AI-driven Drug Discovery Product Offered
Table 119. ReviveMed AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. ReviveMed Main Business
Table 121. ReviveMed Latest Developments
Table 122. Insilico Medicine Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 123. Insilico Medicine AI-driven Drug Discovery Product Offered
Table 124. Insilico Medicine AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Insilico Medicine Main Business
Table 126. Insilico Medicine Latest Developments
Table 127. XtalPi Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 128. XtalPi AI-driven Drug Discovery Product Offered
Table 129. XtalPi AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. XtalPi Main Business
Table 131. XtalPi Latest Developments
Table 132. MindRank Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 133. MindRank AI-driven Drug Discovery Product Offered
Table 134. MindRank AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. MindRank Main Business
Table 136. MindRank Latest Developments
Table 137. DP Technology Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 138. DP Technology AI-driven Drug Discovery Product Offered
Table 139. DP Technology AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. DP Technology Main Business
Table 141. DP Technology Latest Developments
Table 1. AI-driven Drug Discovery Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI-driven Drug Discovery Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Small Molecule Drug
Table 4. Major Players of Biological Modeling
Table 5. Major Players of Structural Biology
Table 6. Major Players of Others
Table 7. AI-driven Drug Discovery Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 9. Global AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Table 10. AI-driven Drug Discovery Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 12. Global AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Table 13. Global AI-driven Drug Discovery Revenue by Player (2021-2026) & ($ millions)
Table 14. Global AI-driven Drug Discovery Revenue Market Share by Player (2021-2026)
Table 15. AI-driven Drug Discovery Key Players Head office and Products Offered
Table 16. AI-driven Drug Discovery Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global AI-driven Drug Discovery Market Size by Region (2021-2026) & ($ millions)
Table 20. Global AI-driven Drug Discovery Market Size Market Share by Region (2021-2026)
Table 21. Global AI-driven Drug Discovery Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global AI-driven Drug Discovery Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas AI-driven Drug Discovery Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas AI-driven Drug Discovery Market Size Market Share by Country (2021-2026)
Table 25. Americas AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Table 27. Americas AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Table 29. APAC AI-driven Drug Discovery Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC AI-driven Drug Discovery Market Size Market Share by Region (2021-2026)
Table 31. APAC AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe AI-driven Drug Discovery Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe AI-driven Drug Discovery Market Size Market Share by Country (2021-2026)
Table 35. Europe AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa AI-driven Drug Discovery Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa AI-driven Drug Discovery Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa AI-driven Drug Discovery Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of AI-driven Drug Discovery
Table 41. Key Market Challenges & Risks of AI-driven Drug Discovery
Table 42. Key Industry Trends of AI-driven Drug Discovery
Table 43. Global AI-driven Drug Discovery Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global AI-driven Drug Discovery Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global AI-driven Drug Discovery Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global AI-driven Drug Discovery Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Entos Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 48. Entos AI-driven Drug Discovery Product Offered
Table 49. Entos AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Entos Main Business
Table 51. Entos Latest Developments
Table 52. Selvita Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 53. Selvita AI-driven Drug Discovery Product Offered
Table 54. Selvita AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Selvita Main Business
Table 56. Selvita Latest Developments
Table 57. Benevolent Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 58. Benevolent AI-driven Drug Discovery Product Offered
Table 59. Benevolent AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Benevolent Main Business
Table 61. Benevolent Latest Developments
Table 62. Exscientia Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 63. Exscientia AI-driven Drug Discovery Product Offered
Table 64. Exscientia AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Exscientia Main Business
Table 66. Exscientia Latest Developments
Table 67. Euretos Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 68. Euretos AI-driven Drug Discovery Product Offered
Table 69. Euretos AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Euretos Main Business
Table 71. Euretos Latest Developments
Table 72. Illumina with AstraZeneca Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 73. Illumina with AstraZeneca AI-driven Drug Discovery Product Offered
Table 74. Illumina with AstraZeneca AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Illumina with AstraZeneca Main Business
Table 76. Illumina with AstraZeneca Latest Developments
Table 77. Novo Nordisk with Microsoft Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 78. Novo Nordisk with Microsoft AI-driven Drug Discovery Product Offered
Table 79. Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Novo Nordisk with Microsoft Main Business
Table 81. Novo Nordisk with Microsoft Latest Developments
Table 82. Iktos Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 83. Iktos AI-driven Drug Discovery Product Offered
Table 84. Iktos AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Iktos Main Business
Table 86. Iktos Latest Developments
Table 87. Aqemia Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 88. Aqemia AI-driven Drug Discovery Product Offered
Table 89. Aqemia AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Aqemia Main Business
Table 91. Aqemia Latest Developments
Table 92. Zephyr AI Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 93. Zephyr AI AI-driven Drug Discovery Product Offered
Table 94. Zephyr AI AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Zephyr AI Main Business
Table 96. Zephyr AI Latest Developments
Table 97. Cyclicarx Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 98. Cyclicarx AI-driven Drug Discovery Product Offered
Table 99. Cyclicarx AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Cyclicarx Main Business
Table 101. Cyclicarx Latest Developments
Table 102. Eli Lilly Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 103. Eli Lilly AI-driven Drug Discovery Product Offered
Table 104. Eli Lilly AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Eli Lilly Main Business
Table 106. Eli Lilly Latest Developments
Table 107. Terray Therapeutics Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 108. Terray Therapeutics AI-driven Drug Discovery Product Offered
Table 109. Terray Therapeutics AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Terray Therapeutics Main Business
Table 111. Terray Therapeutics Latest Developments
Table 112. Ardigen Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 113. Ardigen AI-driven Drug Discovery Product Offered
Table 114. Ardigen AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Ardigen Main Business
Table 116. Ardigen Latest Developments
Table 117. ReviveMed Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 118. ReviveMed AI-driven Drug Discovery Product Offered
Table 119. ReviveMed AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. ReviveMed Main Business
Table 121. ReviveMed Latest Developments
Table 122. Insilico Medicine Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 123. Insilico Medicine AI-driven Drug Discovery Product Offered
Table 124. Insilico Medicine AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Insilico Medicine Main Business
Table 126. Insilico Medicine Latest Developments
Table 127. XtalPi Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 128. XtalPi AI-driven Drug Discovery Product Offered
Table 129. XtalPi AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. XtalPi Main Business
Table 131. XtalPi Latest Developments
Table 132. MindRank Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 133. MindRank AI-driven Drug Discovery Product Offered
Table 134. MindRank AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. MindRank Main Business
Table 136. MindRank Latest Developments
Table 137. DP Technology Details, Company Type, AI-driven Drug Discovery Area Served and Its Competitors
Table 138. DP Technology AI-driven Drug Discovery Product Offered
Table 139. DP Technology AI-driven Drug Discovery Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. DP Technology Main Business
Table 141. DP Technology Latest Developments
LIST OF FIGURES
Figure 1. AI-driven Drug Discovery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI-driven Drug Discovery Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI-driven Drug Discovery Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI-driven Drug Discovery Sales Market Share by Country/Region (2025)
Figure 8. AI-driven Drug Discovery Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI-driven Drug Discovery Market Size Market Share by Type in 2025
Figure 10. AI-driven Drug Discovery in Pharmaceutical and Biotechnology Companies
Figure 11. Global AI-driven Drug Discovery Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 12. AI-driven Drug Discovery in Research Laboratories
Figure 13. Global AI-driven Drug Discovery Market: Research Laboratories (2021-2026) & ($ millions)
Figure 14. Global AI-driven Drug Discovery Market Size Market Share by Application in 2025
Figure 15. Global AI-driven Drug Discovery Revenue Market Share by Player in 2025
Figure 16. Global AI-driven Drug Discovery Market Size Market Share by Region (2021-2026)
Figure 17. Americas AI-driven Drug Discovery Market Size 2021-2026 ($ millions)
Figure 18. APAC AI-driven Drug Discovery Market Size 2021-2026 ($ millions)
Figure 19. Europe AI-driven Drug Discovery Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa AI-driven Drug Discovery Market Size 2021-2026 ($ millions)
Figure 21. Americas AI-driven Drug Discovery Value Market Share by Country in 2025
Figure 22. United States AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC AI-driven Drug Discovery Market Size Market Share by Region in 2025
Figure 27. APAC AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Figure 28. APAC AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Figure 29. China AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 33. India AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe AI-driven Drug Discovery Market Size Market Share by Country in 2025
Figure 36. Europe AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Figure 37. Europe AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Figure 38. Germany AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 39. France AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 40. UK AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa AI-driven Drug Discovery Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Figure 46. Egypt AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 52. APAC AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 53. Europe AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 55. United States AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 56. Canada AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 57. Mexico AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 58. Brazil AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 59. China AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 60. Japan AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 61. Korea AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 63. India AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 64. Australia AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 65. Germany AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 66. France AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 67. UK AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 68. Italy AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 69. Russia AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 70. Egypt AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 71. South Africa AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 72. Israel AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 73. Turkey AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 74. Global AI-driven Drug Discovery Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global AI-driven Drug Discovery Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 1. AI-driven Drug Discovery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI-driven Drug Discovery Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI-driven Drug Discovery Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI-driven Drug Discovery Sales Market Share by Country/Region (2025)
Figure 8. AI-driven Drug Discovery Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI-driven Drug Discovery Market Size Market Share by Type in 2025
Figure 10. AI-driven Drug Discovery in Pharmaceutical and Biotechnology Companies
Figure 11. Global AI-driven Drug Discovery Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 12. AI-driven Drug Discovery in Research Laboratories
Figure 13. Global AI-driven Drug Discovery Market: Research Laboratories (2021-2026) & ($ millions)
Figure 14. Global AI-driven Drug Discovery Market Size Market Share by Application in 2025
Figure 15. Global AI-driven Drug Discovery Revenue Market Share by Player in 2025
Figure 16. Global AI-driven Drug Discovery Market Size Market Share by Region (2021-2026)
Figure 17. Americas AI-driven Drug Discovery Market Size 2021-2026 ($ millions)
Figure 18. APAC AI-driven Drug Discovery Market Size 2021-2026 ($ millions)
Figure 19. Europe AI-driven Drug Discovery Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa AI-driven Drug Discovery Market Size 2021-2026 ($ millions)
Figure 21. Americas AI-driven Drug Discovery Value Market Share by Country in 2025
Figure 22. United States AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC AI-driven Drug Discovery Market Size Market Share by Region in 2025
Figure 27. APAC AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Figure 28. APAC AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Figure 29. China AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 33. India AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe AI-driven Drug Discovery Market Size Market Share by Country in 2025
Figure 36. Europe AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Figure 37. Europe AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Figure 38. Germany AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 39. France AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 40. UK AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa AI-driven Drug Discovery Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa AI-driven Drug Discovery Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa AI-driven Drug Discovery Market Size Market Share by Application (2021-2026)
Figure 46. Egypt AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries AI-driven Drug Discovery Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 52. APAC AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 53. Europe AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 55. United States AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 56. Canada AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 57. Mexico AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 58. Brazil AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 59. China AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 60. Japan AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 61. Korea AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 63. India AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 64. Australia AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 65. Germany AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 66. France AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 67. UK AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 68. Italy AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 69. Russia AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 70. Egypt AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 71. South Africa AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 72. Israel AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 73. Turkey AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
Figure 74. Global AI-driven Drug Discovery Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global AI-driven Drug Discovery Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries AI-driven Drug Discovery Market Size 2027-2032 ($ millions)
